 |
 |
||||||
 |
Testimonios de nuestros clientes |
Su pedido
$0.00 (0 artículos)
| |||||
Genérico Lamivudine - Combivir, Epivir, Epivir (3tc), Epivir Hbv (3tc), Epivir-hbv
|
| ||||||||||||||||||||||||||||||
.gif)
.gif)
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth.
- Sildenafil citrate and pulmonary arterial hypertension
Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure.
- Fruit and vegetables do not reduce overall cancer risk, review concludes
Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people.
- Common painkillers could be linked to male reproductive disorder
The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study.
Nuestra página de facturación está certificada por:
- Aurobindo Pharma receives final approval for Lamivudine+Zidovudine Tablets - Equity Bulls
Zee NewsAurobindo Pharma receives final approval for Lamivudine+Zidovudine TabletsEquity BullsAurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market for Lamivudine & Zidovudine tablets USP 150/300 mg (ANDA 202418) and is ready for launch.
- Lupin, Aurobindo get USFDA nod for HIV drug - Economic Times
Lupin, Aurobindo get USFDA nod for HIV drugEconomic TimesLupin Pharmaceuticals Inc, a subsidiary of Lupin Ltd, has received final approval from US Food and Drug Administration (USFDA) for its generic Lamivudine and Zidovudine combination tablet in strength of 150mg/300 mg, Lupin said in a statement.
- LANDMARK HIV DRUG'S PATENT EXPIRES TODAY - U-T San Diego
LANDMARK HIV DRUG'S PATENT EXPIRES TODAYU-T San DiegoThe FDA approved Combivir (lamivudine/zidovudine) in 1997, greatly changing the treatment of HIV/AIDS.
- Patent expires of landmark HIV drug Combivir - U-T San Diego
Patent expires of landmark HIV drug CombivirU-T San DiegoThe FDA approved Combivir (lamivudine/zidovudine) in 1997, greatly changing the treatment of HIV/AIDS.
- HIV positive patients face bleak future - NewsDay
HIV positive patients face bleak futureNewsDayZimbabwe started phasing out the combination anti-retroviral treatment (ARV) Stavudine, Lamivudine and Nevirapine as its first-line option for the national programme, replacing it with the less toxic Tenofovir and Zidovudine-based regimens.
|
| Copyright © Canadian Pharmacy Online. Todos los derechos reservados. |